Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients.
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2018
Price : $35 *
At a glance
- Drugs Letrozole (Primary) ; Cetrorelix; Chorionic gonadotropin; Follitropin alfa; Menotropin; Triptorelin
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms BROVALE
- 31 Aug 2018 Biomarkers information updated
- 27 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Feb 2018 Planned end date changed from 1 Dec 2021 to 1 Dec 2022.